1.
Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men
in Rakai, Uganda: a randomised trial. The Lancet. 2007;369(9562):657-66.
2.
Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young
men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643-56.
3.
Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial
of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLos
med. 2005;2(11):e298.
5.
WHO U. Joint Strategic Action Framework to Accelerate the Scale-Up of Voluntary Medical
Male Circumcision for HIV Prevention in Eastern and Southern Africa (2012–2016). Geneva:
UNAIDS. 2011.
6.
Njeuhmeli E, Forsythe S, Reed J, et al. Voluntary medical male circumcision: modeling
the impact and cost of expanding male circumcision for HIV prevention in eastern and
southern Africa. PLoS medicine. 2011;8(11):e1001132.
10.
President's Emergency Plan for AIDS Relief. PEPFAR Monitoring, Evaluation, and Reporting
Indicator Reference Guide. Washington DC: PEPFAR; 2015.
11.
Campbell J, Dussault G, Buchan J, et al. A universal truth: no health without a workforce.
Geneva: World Health Organization. 2013.
12.
Phili R, Abdool-Karim Q, Ngesa O. Low adverse event rates following voluntary medical
male circumcision in a high HIV disease burden public sector prevention programme
in South Africa. Journal of the International AIDS Society. 2014;17(1).
13.
Reed J, Grund J, Liu Y, et al. Evaluation of loss-to-follow-up and post-operative
adverse events in a voluntary medical male circumcision program in Nyanza Province,
Kenya. Journal of acquired immune deficiency syndromes (1999). 2015.
14.
Lebina L, Taruberekera N, Milovanovic M, et al. Piloting PrePex for Adult and Adolescent
Male Circumcision in South Africa - Pain Is an Issue. PLoS One. 2015;10(9):e0138755.
15.
Brito MO, Lerebours L, Volquez C, et al. A Clinical Trial to Introduce Voluntary Medical
Male Circumcision for HIV Prevention in Areas of High Prevalence in the Dominican
Republic. PLoS One. 2015;10(9):e0137376.
16.
Kigozi G, Musoke R, Watya S, et al. The safety and acceptance of the PrePex device
for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational
study. PLoS One. 2014;9(8):e100008.
17.
Feldblum PJ, Odoyo-June E, Obiero W, et al. Safety, effectiveness and acceptability
of the PrePex device for adult male circumcision in Kenya. PLoS One. 2014;9(5):e95357.
18.
Ashengo TA, Grund J, Mhlanga M, et al. Feasibility and validity of telephone triage
for adverse events during a voluntary medical male circumcision campaign in Swaziland.
BMC Public Health. 2014;14:858.
19.
Duffy K, Galukande M, Wooding N, et al. Reach and cost-effectiveness of the PrePex
device for safe male circumcision in Uganda. PLoS One. 2013;8(5):e63134.
20.
Herman-Roloff A, Bailey RC, Agot K. Factors associated with the safety of voluntary
medical male circumcision in Nyanza province, Kenya. Bull World Health Organ. 2012;90(10):773-81.
21.
Kohler PK, Namate D, Barnhart S, et al. Classification and rates of adverse events
in a Malawi male circumcision program: impact of quality improvement training. BMC
Health Serv Res. 2016;16(1):61.
23.
Centers for Disease Control and Prevention. Voluntary medical male circumcision-southern
and eastern Africa, 2010-2012. MMWR Morbidity and mortality weekly report [Internet].
2013 August 19, 2016; 62(47):[953 p.]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6247a3.htm.
24.
Lankowski AJ, Siedner MJ, Bangsberg DR, et al. Impact of geographic and transportation-related
barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav. 2014;18(7):1199-223.
25.
Govindasamy D, Meghij J, Negussi EK, et al. Interventions to improve or facilitate
linkage to or retention in pre-ART (HIV) care and initiation of ART in low-and middle-income
settings-a systematic review. Journal of the International AIDS Society. 2014;17(1).
26.
Mukherjee JS, Ivers L, Leandre F, et al. Antiretroviral therapy in resource-poor settings:
decreasing barriers to access and promoting adherence. JAIDS Journal of Acquired Immune
Deficiency Syndromes. 2006;43:S123-S6.
27.
Tuller DM, Bangsberg DR, Senkungu J, et al. Transportation costs impede sustained
adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative
study. AIDS and Behavior. 2010;14(4):778-84.
28.
Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time
to confront challenges to ART adherence in Africa. AIDS care. 2007;19(5):658-65.
29.
Odeny TA, Bailey RC, Bukusi EA, et al. Text Messaging to Improve Attendance at Post-Operative
Clinic Visits after Adult Male Circumcision for HIV Prevention: A Randomized Controlled
Trial. PLoS ONE. 2012;7(9):e43832.
30.
Cole-Lewis H, Kershaw T. Text Messaging as a Tool for Behavior Change in Disease Prevention
and Management. Epidemiologic reviews. 2010;32(1):56-69.
31.
Health UDo, Services H. Using health text messages to improve consumer health knowledge,
behaviors, and outcomes: an environmental scan. 2014. URL: http://www hrsa gov/healthit/txt4tots/environmentalscan pdf [accessed 2015-03-24][WebCite Cache].
2015.
32.
Déglise C, Suggs LS, Odermatt P. SMS for disease control in developing countries:
a systematic review of mobile health applications. Journal of Telemedicine and Telecare.
2012;18(5):273-81.
33.
Mbuagbaw L, Thabane L, Ongolo-Zogo P, et al. The Cameroon Mobile Phone SMS (CAMPS)
trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral
therapy. PloS one. 2012;7(12):e46909.
34.
Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve
adherence to antiretroviral treatment in a resource-limited setting: a randomized
controlled trial of text message reminders. AIDS (London, England). 2011;25(6):825.
35.
Kunutsor S, Walley J, Katabira E, et al. Using mobile phones to improve clinic attendance
amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and
prospective study. AIDS and behavior. 2010;14(6):1347-52.
36.
Odeny TA, Bailey RC, Bukusi EA, et al. Effect of text messaging to deter early resumption
of sexual activity after male circumcision for HIV prevention: a randomized controlled
trial. Journal of acquired immune deficiency syndromes (1999). 2014;65(2):e50.
37.
DeRenzi B, Findlater L, Payne J, et al., editors. Improving community health worker
performance through automated SMS. Proceedings of the fifth international conference
on information and communication technologies and development; 2012: ACM.
38.
Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service
on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.
The Lancet. 2010;376(9755):1838-45.
39.
Perrier T, Dell N, DeRenzi B, et al., editors. Engaging pregnant women in Kenya with
a hybrid computer-human SMS communication system. Proceedings of the 33rd Annual ACM
Conference on Human Factors in Computing Systems; 2015: ACM.
40.
Holeman I, Evans J, Kane D, et al. Mobile health for cancer in low to middle income
countries: priorities for research and development. European journal of cancer care.
2014;23(6):750-6.
41.
Mahmud N, Rodriguez J, Nesbit J. A text message-based intervention to bridge the healthcare
communication gap in the rural developing world. Technology and Health Care. 2010;18(2):137-44.
42.
Feldacker C, Makunike-Chikwinya B, Holec M, et al. Implementing voluntary medical
male circumcision using an innovative, integrated, health systems approach: experiences
from 21 districts in Zimbabwe. Global health action. 2018;11(1):1414997.
43.
Bochner A, C F, B M, et al. Adverse event profile of a mature voluntary medical male
circumcision progra mme performing PrePex and surgical procedures in Zimbabwe. Journal
of the International AIDS Society. 2017(20:21394).
44.
President’s Emergency Plan for AIDS Relief. PEPFAR Monitoring, Evaluation, and Reporting
Indicator Reference Guide. March 2015 ed. Washington DC: PEPFAR; 2015.
45.
Marongwe P. Routine implementation of ZAZIC VMMC program. In: Feldacker C, editor.
Key VMMC follow-up visit details from ZAZIC VMMC Program Officer ed. Harare2016.
46.
Tomlinson M, Rotheram-Borus MJ, Swartz L, et al. Scaling up mHealth: where is the
evidence? PLoS Med. 2013;10(2):e1001382.
47.
DeRenzi B, Borriello G, Jackson J, et al. Mobile Phone Tools for Field‐Based Health
care Workers in Low‐Income Countries. Mount Sinai Journal of Medicine: A Journal of
Translational and Personalized Medicine. 2011;78(3):406-18.
48.
Thirumurthy H, Lester RT. M-health for health behaviour change in resource-limited
settings: applications to HIV care and beyond. Bulletin of the World Health Organization.
2012;90(5):390-2.
49.
Banks K, McDonald SM, Scialom F. Mobile technology and the last mile:“Reluctant innovation”
and FrontlineSMS. innovations. 2011;6(1):7-12.
50.
Jumreornvong O. New Weapon In The War Against AIDS: Your Mobile Phone. Intersect:
The Stanford Journal of Science, Technology and Society. 2014;7(1).
51.
Medic Mobile. Medic Mobile For Antenatal Care: Do-It-Yourself Toolkit: Medic Mobile;
2016 [Available from: http://medicmobile.org/diy.
52.
West D. How mobile devices are transforming healthcare. Issues in technology innovation.
2012;18(1):1-11.
53.
Pathak P. India Vaccination Pilot Progress Report. Medic Mobile and Clif Bar. 2012.
56.
D'Agostino RB, Massaro JM, Sullivan LM. Non‐inferiority trials: design concepts and
issues–the encounters of academic consultants in statistics. Statistics in medicine.
2003;22(2):169-86.
57.
Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials.
2011;12(1):1.
58.
World Health Organization. WHO Technical Advisory Group on Innovations in Male Circumcision:
Evaluation of two adult devices: Meeting report. Geneva, Switzerland: WHO; January,
2013 8/10/2015.
60.
Zimbabwe Ministry of Health and Child Care. Accelerated Strategic and Operational
Plan 2014 – 2018. Harare- Zimbabwe; 2014.
61.
Driessen J, Cioffi M, Alide N, et al. Modeling return on investment for an electronic
medical record system in Lilongwe, Malawi. Journal of the American Medical Informatics
Association. 2013;20(4):743-8.
62.
Schutte C, Tshimanga M, Mugurungi O, et al. Comparative cost analysis of surgical
and PrePex device male circumcision in Zimbabwe and Mozambique. Journal of Acquired
Immune Deficiency Syndromes (1999). 2016;72(Suppl 1):S96.
63.
Finkler SA, Knickman JR, Hendrickson G, et al. A comparison of work-sampling and time-and-motion
techniques for studies in health services research. Health services research. 1993;28(5):577.
64.
Were MC, Sutherland J, Bwana M, et al. Patterns of care in two HIV continuity clinics
in Uganda, Africa: a time-motion study. AIDS care. 2008;20(6):677-82.